Anxa1 is overexpression in patients with hepatocellular carcinoma, gliomas, and adenocarcinomas of the esophagus and pancreas, but loss of expression in adenocarcinoma of the breast and prostate, as well as in squamous cell carcinoma of the esophagus and head and neck [20], [21]. The gene discussed is ANXA1; the disease is glioma.